Research programme: small molecule HIV entry inhibitors - ChemBridge Research Laboratories/Trimeris
Latest Information Update: 19 Mar 2008
At a glance
- Originator ChemBridge Research Laboratories; Trimeris
- Class Small molecules
- Mechanism of Action Virus internalisation inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 20 Jun 2005 Preclinical trials in HIV infections treatment in USA (PO)